世界の血行動態モニタリング装置市場の価値は、2022 年に 14 億 7,000 万ドルと評価され、2023 年から 2030 年にかけて 5.2% のCAGRで拡大すると予想されます。血行力学モニタリング装置は心機能と血流を検査し、患者の心臓血管の状態を評価し、治療の決定を行うのに役立ちます。この市場は、心血管疾患、慢性閉塞性肺疾患（COPD）、呼吸器疾患の有病率の増加、新しい非侵襲性および低侵襲性システムの開発、外科手術技術の急速な進歩など、いくつかの要因によって成長すると予想されます。米国肺協会によると、米国における COPD の有病率は総人口の 6.2% と推定されています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Commodity Flow Analysis
1.5.1.1. Approach 1: Commodity flow approach
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Hemodynamic Monitoring Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing critically ill geriatric population
3.3.1.2. Rise in prevalence of cardiac disorders and diabetes
3.3.1.3. Technological advancements
3.3.2. Market restraint analysis
3.3.2.1. Complications associated with invasive monitoring
3.3.2.2. Stringent regulatory guidelines for product approvals
3.4. Business Environment Analysis
3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.2. Porter’s Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Hemodynamic Monitoring Devices Market: System Type Business Analysis
4.1. Hemodynamic Monitoring Devices Market: System Type Movement & Market Share Analysis, 2022 & 2030
4.2. Invasive
4.2.1. Global Invasive Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3. Minimally Invasive
4.3.1. Global Minimally Invasive Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Non-Invasive
4.4.1. Global Non-Invasive Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Hemodynamic Monitoring Devices Market: Product Business Analysis
5.1. Hemodynamic Monitoring Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
5.2. Disposables
5.2.1. Global Disposables Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3. Monitors
5.3.1. Global Monitors Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Hemodynamic Monitoring Devices Market: End-Use Business Analysis
6.1. Hemodynamic Monitoring Devices Market: End Use Movement & Market Share Analysis, 2022 & 2030
6.2. Hospitals
6.2.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3. Catheterization Labs
6.3.1. Global Catheterization Labs Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Others
6.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Hemodynamic Monitoring Devices Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. Market Share Analysis by Country, 2022
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. MEA
7.3. North America
7.3.1. North America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.3.2. U.S.
7.3.2.1. U.S. Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD BILLION)
7.3.2.2. Key Country Dynamics
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.3. Canada
7.3.3.1. Canada Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.3.3.2. Key Country Dynamics
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.4. Europe
7.4.1. Europe Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.2. Germany
7.4.2.1. Germany Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.2.2. Key Country Dynamics
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.3. UK
7.4.3.1. UK Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.3.2. Key Country Dynamics
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.4. France
7.4.4.1. France Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.4.2. Key Country Dynamics
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.5. Italy
7.4.5.1. Italy Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.5.2. Key Country Dynamics
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.6. Spain
7.4.6.1. Spain Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.6.2. Key Country Dynamics
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.7. Denmark
7.4.7.1. Denmark Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.7.2. Key Country Dynamics
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.8. Sweden
7.4.8.1. Sweden Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.8.2. Key Country Dynamics
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5.
7.4.9. Norway
7.4.9.1. Norway Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.4.9.2. Key Country Dynamics
7.4.9.3. Competitive Scenario
7.4.9.4. Regulatory Framework
7.5. Asia Pacific
7.5.1. Asia Pacific Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.5.2. Japan
7.5.2.1. Japan Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.5.2.2. Key Country Dynamics
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.3. China
7.5.3.1. China Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.5.3.2. Key Country Dynamics
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.4. India
7.5.4.1. India Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.5.4.2. Key Country Dynamics
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.5. South Korea
7.5.5.1. South Korea Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.5.5.2. Key Country Dynamics
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.6. Australia
7.5.6.1. Australia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.5.6.2. Key Country Dynamics
7.5.6.3. Competitive Scenario
7.5.6.4. Regulatory Framework
7.5.7. Thailand
7.5.7.1. Thailand Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.5.7.2. Key Country Dynamics
7.5.7.3. Competitive Scenario
7.5.7.4. Regulatory Framework
7.6. Latin America
7.6.1. Latin America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.6.2. Brazil
7.6.2.1. Brazil Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.6.2.2. Key Country Dynamics
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.3. Mexico
7.6.3.1. Mexico Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.6.3.2. Key Country Dynamics
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.4. Argentina
7.6.4.1. Argentina Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.6.4.2. Key Country Dynamics
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.7. MEA
7.7.1. MEA Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.7.2. South Africa
7.7.2.1. South Africa Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.7.2.2. Key Country Dynamics
7.7.2.3. Competitive Scenario
7.7.2.4. Regulatory Framework
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.7.3.2. Key Country Dynamics
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.7.3.5.
7.7.4. UAE
7.7.4.1. UAE Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.7.4.2. Key Country Dynamics
7.7.4.3. Competitive Scenario
7.7.4.4. Regulatory Framework
7.7.5. Kuwait
7.7.5.1. Kuwait Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
7.7.5.2. Key Country Dynamics
7.7.5.3. Competitive Scenario
7.7.5.4. Regulatory Framework
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Profiles/Listing
8.3.1. Edwards Lifesciences Corporation
8.3.1.1. Overview
8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. GE HealthCare
8.3.2.1. Overview
8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Baxter
8.3.3.1. Overview
8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. ICU Medical
8.3.4.1. Overview
8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Koninklijke Philips N.V
8.3.5.1. Overview
8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Masimo
8.3.6.1. Overview
8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Sramek BioDynamics, Inc.
8.3.7.1. Overview
8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. OsypkaCardiotek GmbH
8.3.8.1. Overview
8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Deltex Medical Group
8.3.9.1. Overview
8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 List of Secondary Sources
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Hemodynamic Monitoring Devices market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Global Hemodynamic Monitoring Devices Market: System Type Outlook Key Takeaways
Fig. 15 Global Hemodynamic Monitoring Devices Market: System Type Movement Analysis
Fig. 16 Global Invasive Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Fig. 17 Global Minimally Invasive Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Fig. 18 Global Non-Invasive Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Fig. 19 Global Hemodynamic Monitoring Devices Market: Product Outlook Key Takeaways
Fig. 20 Global Hemodynamic Monitoring Devices Market: Product Movement Analysis
Fig. 21 Global Disposables Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Fig. 22 Global Monitors Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Fig. 23 Global Hemodynamic Monitoring Devices Market: End-use Outlook Key Takeaways
Fig. 24 Global Hemodynamic Monitoring Devices Market: End-use Movement Analysis
Fig. 25 Global Hospitals Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Fig. 26 Global Catheterization Labs Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Fig. 27 Global Others Market Estimates and Forecast Market, 2018 - 2030 (USD Billion)
Fig. 28 Regional Marketplace: Key Takeaways
Fig. 29 Regional outlook, 2022 & 2030
Fig. 30 Global Hemodynamic Monitoring Devices Market: Region Movement Analysis
Fig. 31 North America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 32 U.S. Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 33 Canada Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 34 Europe Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 35 Germany Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 36 UK Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 37 France Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 38 Italy Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 39 Spain Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 40 Denmark Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 41 Sweden Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 42 Norway Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 43 Asia pacific Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 44 Japan Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 45 China Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 46 India Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 47 Australia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 48 South Korea Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 49 Thailand Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 50 Latin America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 51 Brazil Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 52 Mexico Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 53 Argentina Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 54 Middle East and Africa Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 55 South Africa Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 56 Saudi Arabia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 57 Kuwait Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
Fig. 58 UAE Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
